Sector ratings Grifols, S.A.

Equities

Real-time Estimate Tradegate Other stock markets 13:47:05 18/11/2025 GMT			5-day change	1st Jan Change
10.28 ^EUR	-2.93%		-4.01%	+12.54%

10:34am	Grifols Says it Gets US FDA's Expanded Indication for Thrombate III for Pediatric Patients	MT
09:09am	Grifols gets FDA approval for Thrombate III in pediatric patients in U.S.	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
GRIFOLS, S.A.	7.43B		BB
REGENERON PHARMACEUTICALS, INC.	72.26B		A
SAMSUNG BIOLOGICS CO.,LTD.	59.52B		BBB
CSL LIMITED	56.7B		AA
UCB	50.37B		AA
BIOGEN INC.	24.16B		AA
INCYTE CORPORATION	20.45B		AA
ALTEOGEN INC.	20.07B		CCC
INNOVENT BIOLOGICS, INC.	20.02B		AAA
INTRA-CELLULAR THERAPIES, INC.	14.02B	-	BBB	-		-	-
BRIDGEBIO PHARMA, INC.	12.89B	-	BB	-		-
SWEDISH ORPHAN BIOVITRUM AB	12.27B		AA
AVIDITY BIOSCIENCES, INC.	10.65B	-	BB	-		-
BIOMARIN PHARMACEUTICAL INC.	10.46B		BBB
3SBIO INC.	10.19B		AA
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	9.8B	-	B	-		-	-
MODERNA, INC.	9.67B	-	A	-		-
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.	7.56B	-	-	-	-	-	-	-
AXSOME THERAPEUTICS, INC.	7.34B	-	BB	-		-
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	7.15B		AA
Average	22.15B		A
Weighted average by Cap.			A